dhusark glp 1 GLP-1 & Microdosing dhusark glp 1 GLP-1-based therapy

No exceda las dosis recomendadas

Close 3 Mar 2026 | ~03:18 Engagement Time Many people living with multiple sclerosis are already taking GLP-1 medications or seriously considering them for weight management, diabetes, or metabolic health

Purpose-built for physicians GLP-1 receptor agonists may reduce hidradenitis suppurativa surgeries, hospitalizations Key takeaways: Hidradenitis suppurativa is associated with repeat surgeries and hospitalizations

Clinical trials have shown that weight loss with these medications typically ranges from 10-20% of body weight, depending on the specific agent and dosage, with tirzepatide showing the highest average weight reduction

Moreover, it promotes the secretion of macrophage colony-stimulating factor (MCSF) and NF-B receptor activator (RANKL), which contribute to bone destruction

As an antioxidant, glutathione helps to repair damaged DNA and skin cell proteins, to support cellular turnover and regeneration